NEW YORK (GenomeWeb News) – DeCode Genetics reported after the close of the market on Monday that its revenues for the first quarter declined 41 percent due primarily to lower contract service revenues — but the firm also substantially cut its net loss year over year.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.